DOTA-JR11, CAS 1039726-31-2

Product Description: DOTA-JR11 is a somatostatin receptor 2 （SSTR2）antagonist. DOTA-JR11 can be labeled by 68Ga, used for paired imaging in neuroendocrine tumors (NETs) research[1].

Applications: Cancer-programmed cell death

Formula: C74H98ClN19O21S2

References: [1]Krebs S, et al. Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3047-3057.

CAS Number: 1039726-31-2

Molecular Weight: 1689.27

Compound Purity: 98.39

Research Area: Cancer

Solubility: DMSO : 25 mg/mL (ultrasonic)

Target: Somatostatin Receptor

• Artikelnummer: MEXHY-P5128-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P5128-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK